Evidence map›Paper›PMID 23873521›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2014

Detection of clinical relapses in multiple sclerosis cohorts: construction and validation of a model based on administrative data.

Roberto Bergamaschi, Mauro Agnello, Elena Colombo, Mirosa Della Giovanna, Cristina Montomoli, Antonio Nava, Pietro Perotti, Maurizio Riva, Isabella Ruggeri, Renato Scola and 5 more

Abstract readValidation Study
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 2 countries.

Roberto BergamaschiInter-department Multiple Sclerosis Research Centre, C. Mondino National Institute of Neurology Foundation, IRCCS, via Mondino 2, 27100, Pavia, Italy, roberto.bergamaschi@mondino.it.
Mauro Agnello
Elena Colombo
Mirosa Della Giovanna
Cristina Montomoli
Antonio Nava
Pietro Perotti
Maurizio Riva
Isabella Ruggeri
Renato Scola
Maria Grazia Silvestri
Michele Tringali
Babila Uggeri
Giovandomenico Violante
Mauro Zaffaroni
Ospedale Maggiore di Lodi · ITFondazione Istituto Neurologico Nazionale Casimiro Mondino · ITAssociazione Italiana Sclerosi Multipla · ITAzienda di Servizi alla Persona di Pavia (Italy) · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITLuigi Sacco Hospital · ITRegione LombardiaUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple sclerosis (MS) is the main cause of chronic disability in young people during their most productive years of life and therefore carries a high social and economic burden. The present study aimed to: (1) verify the capacity of an administrative data source to furnish data for constructing a model able to detect the occurrence of clinical relapses in MS patients and (2) validate the constructed theoretical model on a set of real-world data. Two MS experts identified some administrative variables as proxies of clinical relapses. Thereafter, the two MS experts analysed 889 events in 100 MS patients, considering only the administrative data relating to these patients, while a third neurologist independently analysed the real-world data (documented medical history) of the same patients in the same period. Absolute concordance between the theoretical model and the real-world data was found in 86 % of the events. The model we propose is easily and rapidly applicable, requiring the collection of just a few variables that are already present in local health authority administrative databases in Italy. It can be used to estimate, with a good level of reliability, the occurrence of relapses in various settings. Moreover, the model is also exportable to different and larger MS cohorts and could be useful for healthcare planning and for evaluating the efficacy of drugs in the real-world, thus favouring better resource allocation and management.

Indexed as

Models, NeurologicalDatabases, FactualFemaleHumansItalyMaleMultiple SclerosisMultiple Sclerosis, Relapsing-RemittingRecurrence

Identifiers

PMID23873521
OpenAlexW2001012796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.